NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model. - Meraz IM; Majidi M; Song R; Meng F; Gao L; Wang Q; Wang J; Shpall EJ; Roth JA (ELife, 2025)